Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod 5 Pods
Insulet has launched a voluntary medical device correction for specific lots of Omnipod 5 Pods due to possible tubing issues. All other pods remain safe.
Insulet has launched a voluntary medical device correction for specific lots of Omnipod 5 Pods due to possible tubing issues. All other pods remain safe.
Adobe smashed Q1 2026 records with $6.4B revenue and AI growth tripling, plus strong Q2 guidance. But CEO Shantanu Narayen is transitioning out, and shares fell 6% on AI competition fears.
Morgan Stanley and Cliffwater limit redemptions on major private credit funds after record withdrawal requests in Q1 2026, signaling investor concerns over liquidity and loan quality in the $1.8T market.
Hunterbrook report reveals Himax as stealth supplier of key optical components for Nvidia's AI data centers and possibly Apple's smart glasses. Stock jumps amid massive upside potential in CPO and AR tech.
Wolfpack Research released a critical short report questioning Babcock & Wilcox's $2.4 billion deal with Base Electron, a new RILY-backed company. APLD contradicts BW's claims and already has grid power agreements, casting major doubt on the project.
Lucid steps up competition against Tesla by unveiling a two-seater robotaxi concept called Lunar (no steering wheel!) and a flexible self-driving subscription. Meanwhile, Rivian reveals higher launch pricing for its R2 SUV.